This Antibody was verified by Cell treatment to ensure that the antibody binds to the antigen stated. View Details
PA1-749 detects ataxin 7 protein from transfected cell lysate.\r
PA1-749 has successfully been used in immunohistochemistry and Western blot procedures. By Western blot, this antibody detects an ~96 kDa protein representing human ataxin 7 in transfected COS-1 cells.\r
The PA1-749 immunizing peptide corresponds to amino acid residues 1-17 from human ataxin 7. This sequence is completely conserved in mouse ataxin 7. This peptide (Cat. # PEP-217) is available for use in neutralization and control experiments.
Spinocerebellar ataxia type 7 (SCA7) belongs to a class of hereditary neurodegenrative diseases characterized by abnormally expanded polyglutamine (CAG) repeats at the N-terminus. This autosomal dominant cerebellar ataxia primarily affects the cerebellum, retina, and brain stem and causes dementia, macular degeneration and other neurodegenerative characteristics. SCA7 gene encodes the ubiquitous 892 residue protein ataxin-7. This protein is typically located in the cytoplasm and on the nuclear membrane of normal brain neurons. In cells where there is a mutation of the SCA7 gene, ataxin 7 accumulates in intranuclear inclusions and can result in cell death.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Ataxin-7; Atxn7-PA; Atxn7-PB; Atxn7-PC; Atxn7-PD; CG9866-PA; CG9866-PB; CG9866-PC; CG9866-PD; LD40170p; Spinocerebellar ataxia type 7 protein
Gene Aliases: ADCAII; Ataxin7; ATXN7; CG9866; Dmel\CG9866; Dmel_CG9866; OPCA3; SCA7
UniProt ID: (Human) O15265